BRAF and neoplasm: Univariate analyses also revealed a significantly higher likelihood of tumor relapse or tumor-related death among patients with PTCs whose cells showed TERT amplification concurring with other genetic alterations such as TPM, BRAF, or TPM + BRAF mutations (see Table 4).